Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1950 1
1951 1
1953 1
1956 3
1964 1
1968 2
1970 1
1972 1
1973 1
1975 1
1978 1
1980 1
1983 2
1984 1
1985 2
1987 3
1989 2
1990 5
1991 7
1992 4
1993 1
1994 5
1995 6
1996 7
1997 7
1998 4
1999 4
2000 5
2001 10
2002 9
2003 15
2004 13
2005 10
2006 9
2007 19
2008 12
2009 13
2010 9
2011 21
2012 23
2013 21
2014 31
2015 14
2016 24
2017 46
2018 72
2019 112
2020 168
2021 186
2022 138
2023 130
2024 173
2025 204
2026 129

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,515 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: zainat
Page 1
Showing results for zainat komen
Your search for zinat komeh retrieved no results
Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research.
Jagsi R, Mason G, Overmoyer BA, Woodward WA, Badve S, Schneider RJ, Lang JE, Alpaugh M, Williams KP, Vaught D, Smith A, Smith K, Miller KD; Susan G. Komen-IBCRF IBC Collaborative in partnership with the Milburn Foundation. Jagsi R, et al. Breast Cancer Res Treat. 2022 Apr;192(2):235-243. doi: 10.1007/s10549-021-06434-x. Epub 2022 Jan 1. Breast Cancer Res Treat. 2022. PMID: 34973083 Free PMC article. Review.
A key challenge relates to the need for a more detailed, formal, objective definition of IBC, the lack of which compromises clinical care, hampers the conduct of clinical trials, and hinders the search for IBC-specific biomarkers and treatments because of the heterogeneity of pat …
A key challenge relates to the need for a more detailed, formal, objective definition of IBC, the lack of which compromises clinical care, h …
Update on 18F-Fluoroestradiol.
O'Brien SR, Edmonds CE, Ward RE, Taunk NK, Pantel AR, Mankoff DA. O'Brien SR, et al. Semin Nucl Med. 2024 Nov;54(6):812-826. doi: 10.1053/j.semnuclmed.2024.09.001. Epub 2024 Oct 5. Semin Nucl Med. 2024. PMID: 39368910 Review.
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study.
Chua BH, Link EK, Kunkler IH, Whelan TJ, Westenberg AH, Gruber G, Bryant G, Ahern V, Purohit K, Graham PH, Akra M, McArdle O, O'Brien P, Harvey JA, Kirkove C, Maduro JH, Campbell ID, Delaney GP, Martin JD, Vu TTT, Muanza TM, Neal A, Olivotto IA; BIG 3–07/TROG 07.01 trial investigators. Chua BH, et al. Lancet. 2022 Aug 6;400(10350):431-440. doi: 10.1016/S0140-6736(22)01246-6. Lancet. 2022. PMID: 35934006 Clinical Trial.
FUNDING: National Health and Medical Research Council of Australia, Susan G Komen for the Cure, Breast Cancer Now, OncoSuisse, Dutch Cancer Society, Canadian Cancer Trials Group....
FUNDING: National Health and Medical Research Council of Australia, Susan G Komen for the Cure, Breast Cancer Now, OncoSuisse, Dutch …
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.
Kitko CL, Arora M, DeFilipp Z, Zaid MA, Di Stasi A, Radojcic V, Betts CB, Coussens LM, Meyers ML, Qamoos H, Ordentlich P, Kumar V, Quaranto C, Schmitt A, Gu Y, Blazar BR, Wang TP, Salhotra A, Pusic I, Jagasia M, Lee SJ. Kitko CL, et al. J Clin Oncol. 2023 Apr 1;41(10):1864-1875. doi: 10.1200/JCO.22.00958. Epub 2022 Dec 2. J Clin Oncol. 2023. PMID: 36459673 Free PMC article. Clinical Trial.
A predictor of response in HER2+ breast cancer-at last!
Badve SS, Gökmen-Polar Y. Badve SS, et al. J Natl Cancer Inst. 2023 Mar 9;115(3):242-245. doi: 10.1093/jnci/djac228. J Natl Cancer Inst. 2023. PMID: 36576003 Free PMC article. No abstract available.
1,515 results